BOLT - Bolt Biotherapeutics GAAP EPS of -$0.45 revenue of $1.83M May, 11 2023 05:02 PM Bolt Biotherapeutics Inc. 2023-05-11 17:02:28 ET Bolt Biotherapeutics press release ( NASDAQ: BOLT ): Q1 GAAP EPS of -$0.45. Revenue of $1.83M (+125.9% Y/Y). For further details see: Bolt Biotherapeutics GAAP EPS of -$0.45, revenue of $1.83M